▶ 調査レポート

ナノテクノロジードラッグデリバリーの世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Nanotechnology Drug Delivery Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。ナノテクノロジードラッグデリバリーの世界市場2020年:企業別、地域別、種類・用途別 / Global Nanotechnology Drug Delivery Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0GIR-01607資料のイメージです。• レポートコード:D0GIR-01607
• 出版社/出版日:GlobalInfoResearch / 2020年9月23日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ナノテクノロジードラッグデリバリーの世界市場を広く調査・分析し、今後の市場展望をまとめております。ナノテクノロジードラッグデリバリーの種類別市場規模(ナノクリスタル、ナノ粒子、リポソーム、ミセル、ナノチューブ、その他)、用途別市場規模(神経、腫瘍、心臓血管・生理、抗炎症・免疫、抗感染症、その他の用途)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):AbbVie, Inc.、Pfizer, Inc.、Johnson & Johnson、Amgen Inc.、Perrigo Company plc、Celgene Corporation、Novartis International AG、Merck & Co., Inc.、Teva Pharmaceutical Industries Ltd.
・地域別グローバル市場分析 2015年-2020年
・ナノテクノロジードラッグデリバリーの北米市場(アメリカ、カナダ、メキシコ)
・ナノテクノロジードラッグデリバリーのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ナノテクノロジードラッグデリバリーのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ナノテクノロジードラッグデリバリーの南米市場(ブラジル、アルゼンチン)
・ナノテクノロジードラッグデリバリーの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ナノクリスタル、ナノ粒子、リポソーム、ミセル、ナノチューブ、その他
・用途別分析:神経、腫瘍、心臓血管・生理、抗炎症・免疫、抗感染症、その他の用途
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Nanotechnology Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 8000.6 million by 2025, from USD 6153.4 million in 2019.

The Nanotechnology Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Nanotechnology Drug Delivery market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Nanotechnology Drug Delivery market has been segmented into:
Nanocrystals
Nanoparticles
Liposomes
Micelles
Nanotubes
Others

By Application, Nanotechnology Drug Delivery has been segmented into:
Neurology
Oncology
Cardiovascular/Physiology
Anti-inflammatory/Immunology
Anti-infective
Other Applications

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nanotechnology Drug Delivery market presented in the report. This section sheds light on the sales growth of different regional and country-level Nanotechnology Drug Delivery markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nanotechnology Drug Delivery market.

The report offers in-depth assessment of the growth and other aspects of the Nanotechnology Drug Delivery market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Nanotechnology Drug Delivery Market Share Analysis
Nanotechnology Drug Delivery competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nanotechnology Drug Delivery sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nanotechnology Drug Delivery sales, revenue and market share for each player covered in this report.

The major players covered in Nanotechnology Drug Delivery are:
AbbVie, Inc.
Pfizer, Inc.
Johnson & Johnson
Amgen Inc.
Perrigo Company plc
Celgene Corporation
Novartis International AG
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.

レポート目次

Table of Contents

1 Nanotechnology Drug Delivery Market Overview
1.1 Product Overview and Scope of Nanotechnology Drug Delivery
1.2 Classification of Nanotechnology Drug Delivery by Type
1.2.1 Global Nanotechnology Drug Delivery Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nanotechnology Drug Delivery Revenue Market Share by Type in 2019
1.2.3 Nanocrystals
1.2.4 Nanoparticles
1.2.5 Liposomes
1.2.6 Micelles
1.2.7 Nanotubes
1.2.8 Others
1.3 Global Nanotechnology Drug Delivery Market by Application
1.3.1 Overview: Global Nanotechnology Drug Delivery Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Neurology
1.3.3 Oncology
1.3.4 Cardiovascular/Physiology
1.3.5 Anti-inflammatory/Immunology
1.3.6 Anti-infective
1.3.7 Other Applications
1.4 Global Nanotechnology Drug Delivery Market by Regions
1.4.1 Global Nanotechnology Drug Delivery Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nanotechnology Drug Delivery (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nanotechnology Drug Delivery Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nanotechnology Drug Delivery Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nanotechnology Drug Delivery Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nanotechnology Drug Delivery Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nanotechnology Drug Delivery Status and Prospect (2015-2025)
2 Company Profiles
2.1 AbbVie, Inc.
2.1.1 AbbVie, Inc. Details
2.1.2 AbbVie, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie, Inc. SWOT Analysis
2.1.4 AbbVie, Inc. Product and Services
2.1.5 AbbVie, Inc. Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer, Inc.
2.2.1 Pfizer, Inc. Details
2.2.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer, Inc. SWOT Analysis
2.2.4 Pfizer, Inc. Product and Services
2.2.5 Pfizer, Inc. Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen Inc.
2.4.1 Amgen Inc. Details
2.4.2 Amgen Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen Inc. SWOT Analysis
2.4.4 Amgen Inc. Product and Services
2.4.5 Amgen Inc. Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.5 Perrigo Company plc
2.5.1 Perrigo Company plc Details
2.5.2 Perrigo Company plc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Perrigo Company plc SWOT Analysis
2.5.4 Perrigo Company plc Product and Services
2.5.5 Perrigo Company plc Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.6 Celgene Corporation
2.6.1 Celgene Corporation Details
2.6.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Celgene Corporation SWOT Analysis
2.6.4 Celgene Corporation Product and Services
2.6.5 Celgene Corporation Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis International AG
2.7.1 Novartis International AG Details
2.7.2 Novartis International AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis International AG SWOT Analysis
2.7.4 Novartis International AG Product and Services
2.7.5 Novartis International AG Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck & Co., Inc.
2.8.1 Merck & Co., Inc. Details
2.8.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck & Co., Inc. SWOT Analysis
2.8.4 Merck & Co., Inc. Product and Services
2.8.5 Merck & Co., Inc. Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva Pharmaceutical Industries Ltd.
2.9.1 Teva Pharmaceutical Industries Ltd. Details
2.9.2 Teva Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis
2.9.4 Teva Pharmaceutical Industries Ltd. Product and Services
2.9.5 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nanotechnology Drug Delivery Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nanotechnology Drug Delivery Players Market Share
3.2.2 Top 10 Nanotechnology Drug Delivery Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nanotechnology Drug Delivery Revenue and Market Share by Regions
4.2 North America Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
4.3 Europe Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
4.5 South America Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
5 North America Nanotechnology Drug Delivery Revenue by Countries
5.1 North America Nanotechnology Drug Delivery Revenue by Countries (2015-2020)
5.2 USA Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
5.3 Canada Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
5.4 Mexico Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
6 Europe Nanotechnology Drug Delivery Revenue by Countries
6.1 Europe Nanotechnology Drug Delivery Revenue by Countries (2015-2020)
6.2 Germany Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
6.3 UK Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
6.4 France Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
6.5 Russia Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
6.6 Italy Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nanotechnology Drug Delivery Revenue by Countries
7.1 Asia-Pacific Nanotechnology Drug Delivery Revenue by Countries (2015-2020)
7.2 China Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
7.3 Japan Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
7.4 Korea Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
7.5 India Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
8 South America Nanotechnology Drug Delivery Revenue by Countries
8.1 South America Nanotechnology Drug Delivery Revenue by Countries (2015-2020)
8.2 Brazil Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
8.3 Argentina Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nanotechnology Drug Delivery by Countries
9.1 Middle East & Africa Nanotechnology Drug Delivery Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
9.3 UAE Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
9.4 Egypt Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
9.5 South Africa Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nanotechnology Drug Delivery Revenue and Market Share by Type (2015-2020)
10.2 Global Nanotechnology Drug Delivery Market Forecast by Type (2019-2024)
10.3 Nanocrystals Revenue Growth Rate (2015-2025)
10.4 Nanoparticles Revenue Growth Rate (2015-2025)
10.5 Liposomes Revenue Growth Rate (2015-2025)
10.6 Micelles Revenue Growth Rate (2015-2025)
10.7 Nanotubes Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Nanotechnology Drug Delivery Market Segment by Application
11.1 Global Nanotechnology Drug Delivery Revenue Market Share by Application (2015-2020)
11.2 Nanotechnology Drug Delivery Market Forecast by Application (2019-2024)
11.3 Neurology Revenue Growth (2015-2020)
11.4 Oncology Revenue Growth (2015-2020)
11.5 Cardiovascular/Physiology Revenue Growth (2015-2020)
11.6 Anti-inflammatory/Immunology Revenue Growth (2015-2020)
11.7 Anti-infective Revenue Growth (2015-2020)
11.8 Other Applications Revenue Growth (2015-2020)
12 Global Nanotechnology Drug Delivery Market Size Forecast (2021-2025)
12.1 Global Nanotechnology Drug Delivery Market Size Forecast (2021-2025)
12.2 Global Nanotechnology Drug Delivery Market Forecast by Regions (2021-2025)
12.3 North America Nanotechnology Drug Delivery Revenue Market Forecast (2021-2025)
12.4 Europe Nanotechnology Drug Delivery Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nanotechnology Drug Delivery Revenue Market Forecast (2021-2025)
12.6 South America Nanotechnology Drug Delivery Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nanotechnology Drug Delivery Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Nanotechnology Drug Delivery Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nanotechnology Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nanotechnology Drug Delivery Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nanotechnology Drug Delivery Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AbbVie, Inc. Corporate Information, Location and Competitors
Table 6. AbbVie, Inc. Nanotechnology Drug Delivery Major Business
Table 7. AbbVie, Inc. Nanotechnology Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 8. AbbVie, Inc. SWOT Analysis
Table 9. AbbVie, Inc. Nanotechnology Drug Delivery Product and Solutions
Table 10. AbbVie, Inc. Nanotechnology Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pfizer, Inc. Corporate Information, Location and Competitors
Table 12. Pfizer, Inc. Nanotechnology Drug Delivery Major Business
Table 13. Pfizer, Inc. Nanotechnology Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer, Inc. SWOT Analysis
Table 15. Pfizer, Inc. Nanotechnology Drug Delivery Product and Solutions
Table 16. Pfizer, Inc. Nanotechnology Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson Corporate Information, Location and Competitors
Table 18. Johnson & Johnson Nanotechnology Drug Delivery Major Business
Table 19. Johnson & Johnson Nanotechnology Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 20. Johnson & Johnson SWOT Analysis
Table 21. Johnson & Johnson Nanotechnology Drug Delivery Product and Solutions
Table 22. Johnson & Johnson Nanotechnology Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Amgen Inc. Corporate Information, Location and Competitors
Table 24. Amgen Inc. Nanotechnology Drug Delivery Major Business
Table 25. Amgen Inc. Nanotechnology Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 26. Amgen Inc. SWOT Analysis
Table 27. Amgen Inc. Nanotechnology Drug Delivery Product and Solutions
Table 28. Amgen Inc. Nanotechnology Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Perrigo Company plc Corporate Information, Location and Competitors
Table 30. Perrigo Company plc Nanotechnology Drug Delivery Major Business
Table 31. Perrigo Company plc Nanotechnology Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 32. Perrigo Company plc SWOT Analysis
Table 33. Perrigo Company plc Nanotechnology Drug Delivery Product and Solutions
Table 34. Perrigo Company plc Nanotechnology Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Celgene Corporation Corporate Information, Location and Competitors
Table 36. Celgene Corporation Nanotechnology Drug Delivery Major Business
Table 37. Celgene Corporation Nanotechnology Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 38. Celgene Corporation SWOT Analysis
Table 39. Celgene Corporation Nanotechnology Drug Delivery Product and Solutions
Table 40. Celgene Corporation Nanotechnology Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Novartis International AG Corporate Information, Location and Competitors
Table 42. Novartis International AG Nanotechnology Drug Delivery Major Business
Table 43. Novartis International AG Nanotechnology Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 44. Novartis International AG SWOT Analysis
Table 45. Novartis International AG Nanotechnology Drug Delivery Product and Solutions
Table 46. Novartis International AG Nanotechnology Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Merck & Co., Inc. Corporate Information, Location and Competitors
Table 48. Merck & Co., Inc. Nanotechnology Drug Delivery Major Business
Table 49. Merck & Co., Inc. Nanotechnology Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 50. Merck & Co., Inc. SWOT Analysis
Table 51. Merck & Co., Inc. Nanotechnology Drug Delivery Product and Solutions
Table 52. Merck & Co., Inc. Nanotechnology Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Teva Pharmaceutical Industries Ltd. Corporate Information, Location and Competitors
Table 54. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Major Business
Table 55. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Total Revenue (USD Million) (2017-2018)
Table 56. Teva Pharmaceutical Industries Ltd. SWOT Analysis
Table 57. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Product and Solutions
Table 58. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Nanotechnology Drug Delivery Revenue (Million USD) by Players (2015-2020)
Table 60. Global Nanotechnology Drug Delivery Revenue Share by Players (2015-2020)
Table 61. Global Nanotechnology Drug Delivery Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Nanotechnology Drug Delivery Revenue Market Share by Regions (2015-2020)
Table 63. North America Nanotechnology Drug Delivery Revenue by Countries (2015-2020)
Table 64. North America Nanotechnology Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 65. Europe Nanotechnology Drug Delivery Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Nanotechnology Drug Delivery Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Nanotechnology Drug Delivery Revenue by Countries (2015-2020)
Table 68. South America Nanotechnology Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Nanotechnology Drug Delivery Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Nanotechnology Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 71. Global Nanotechnology Drug Delivery Revenue (Million USD) by Type (2015-2020)
Table 72. Global Nanotechnology Drug Delivery Revenue Share by Type (2015-2020)
Table 73. Global Nanotechnology Drug Delivery Revenue Forecast by Type (2021-2025)
Table 74. Global Nanotechnology Drug Delivery Revenue by Application (2015-2020)
Table 75. Global Nanotechnology Drug Delivery Revenue Share by Application (2015-2020)
Table 76. Global Nanotechnology Drug Delivery Revenue Forecast by Application (2021-2025)
Table 77. Global Nanotechnology Drug Delivery Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nanotechnology Drug Delivery Picture
Figure 2. Global Nanotechnology Drug Delivery Revenue Market Share by Type in 2019
Figure 3. Nanocrystals Picture
Figure 4. Nanoparticles Picture
Figure 5. Liposomes Picture
Figure 6. Micelles Picture
Figure 7. Nanotubes Picture
Figure 8. Others Picture
Figure 9. Nanotechnology Drug Delivery Revenue Market Share by Application in 2019
Figure 10. Neurology Picture
Figure 11. Oncology Picture
Figure 12. Cardiovascular/Physiology Picture
Figure 13. Anti-inflammatory/Immunology Picture
Figure 14. Anti-infective Picture
Figure 15. Other Applications Picture
Figure 16. Global Nanotechnology Drug Delivery Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Nanotechnology Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Nanotechnology Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Nanotechnology Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Nanotechnology Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Nanotechnology Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Nanotechnology Drug Delivery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Nanotechnology Drug Delivery Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Nanotechnology Drug Delivery Revenue Market Share in 2019
Figure 25. Global Top 10 Players Nanotechnology Drug Delivery Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Nanotechnology Drug Delivery Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Nanotechnology Drug Delivery Revenue Market Share by Regions (2015-2020)
Figure 29. Global Nanotechnology Drug Delivery Revenue Market Share by Regions in 2018
Figure 30. North America Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 31. Europe Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 33. South America Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 35. North America Nanotechnology Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 36. North America Nanotechnology Drug Delivery Revenue Market Share by Countries in 2019
Figure 37. USA Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 38. Canada Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 40. Europe Nanotechnology Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Nanotechnology Drug Delivery Revenue Market Share by Countries in 2019
Figure 42. Germany Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 43. UK Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 44. France Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 45. Russia Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 46. Italy Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Nanotechnology Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Nanotechnology Drug Delivery Revenue Market Share by Countries in 2019
Figure 49. China Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 50. Japan Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 51. Korea Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 52. India Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 54. South America Nanotechnology Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 55. South America Nanotechnology Drug Delivery Revenue Market Share by Countries in 2019
Figure 56. Brazil Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Nanotechnology Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Nanotechnology Drug Delivery Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 61. UAE Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Nanotechnology Drug Delivery Revenue and Growth Rate (2015-2020)
Figure 64. Global Nanotechnology Drug Delivery Revenue Share by Type (2015-2020)
Figure 65. Global Nanotechnology Drug Delivery Revenue Share by Type in 2019
Figure 66. Global Nanotechnology Drug Delivery Market Share Forecast by Type (2021-2025)
Figure 67. Global Nanocrystals Revenue Growth Rate (2015-2020)
Figure 68. Global Nanoparticles Revenue Growth Rate (2015-2020)
Figure 69. Global Liposomes Revenue Growth Rate (2015-2020)
Figure 70. Global Micelles Revenue Growth Rate (2015-2020)
Figure 71. Global Nanotubes Revenue Growth Rate (2015-2020)
Figure 72. Global Others Revenue Growth Rate (2015-2020)
Figure 73. Global Nanotechnology Drug Delivery Revenue Share by Application (2015-2020)
Figure 74. Global Nanotechnology Drug Delivery Revenue Share by Application in 2019
Figure 75. Global Nanotechnology Drug Delivery Market Share Forecast by Application (2021-2025)
Figure 76. Global Neurology Revenue Growth Rate (2015-2020)
Figure 77. Global Oncology Revenue Growth Rate (2015-2020)
Figure 78. Global Cardiovascular/Physiology Revenue Growth Rate (2015-2020)
Figure 79. Global Anti-inflammatory/Immunology Revenue Growth Rate (2015-2020)
Figure 80. Global Anti-infective Revenue Growth Rate (2015-2020)
Figure 81. Global Other Applications Revenue Growth Rate (2015-2020)
Figure 82. Global Nanotechnology Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Nanotechnology Drug Delivery Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Nanotechnology Drug Delivery Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Nanotechnology Drug Delivery Revenue Market Forecast (2021-2025)
Figure 86. Europe Nanotechnology Drug Delivery Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Nanotechnology Drug Delivery Revenue Market Forecast (2021-2025)
Figure 88. South America Nanotechnology Drug Delivery Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Nanotechnology Drug Delivery Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel